140 filings
Page 6 of 7
8-K
p45wpg6t el6uufi
23 Mar 20
Milestone Pharmaceuticals Announces Topline Results from First-of-its-kind Phase 3 NODE-301 Trial of Etripamil for At-home Acute PSVT Treatment
5:19pm
10-K
2aqjs0mp21ek0tfpbk
6 Mar 20
Annual report
7:07am
S-8
78lzi7ufreycc1
6 Mar 20
Registration of securities for employees
12:00am
8-K
nuwelotv hmveldujroq
17 Dec 19
Other Events
4:05pm
8-K
sgrx6vyiq6 ky
3 Dec 19
Departure of Directors or Certain Officers
4:56pm
8-K
pr53m8vtapgax9bckn1
13 Nov 19
Milestone Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Clinical and Corporate Update
7:13am
8-K
wtm ziuil
15 Oct 19
Departure of Directors or Certain Officers
6:52am
8-K
k52va
20 Sep 19
Departure of Directors or Certain Officers
6:02am
8-K
nca1d2a53tbdgply1e
10 Sep 19
Milestone Pharmaceuticals Announces Appointment of Amit Hasija as Chief Financial Officer and Executive Vice President of Corporate Development
8:45am
8-K
3wuxawvare8 mb5w
13 Aug 19
Results of Operations and Financial Condition
7:05am
10-Q
teoyle3rsc01x
19 Jun 19
Quarterly report
4:06pm
8-K
cm53vns1et37hjvm0
24 May 19
Condensed Consolidated Financial Statements
4:47pm
8-K
8d9yfhcneeu3a
15 May 19
Milestone Pharmaceuticals Announces Closing of Initial Public Offering
5:26pm
S-8
e4ckbq
9 May 19
Registration of securities for employees
5:24pm
424B4
019mr
9 May 19
Prospectus supplement with pricing info
4:54pm
EFFECT
wo6mwccqqzfhr
9 May 19
Notice of effectiveness
12:15am
S-1MEF
aeoba
8 May 19
Registration of additional securities for an S-1
9:07pm
CERT
rfilfenv2iqn k9i
7 May 19
Certification of approval for exchange listing
11:06am